CD56 positive intestinal T-cell lymphoma: Treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation

Internal Medicine

Volumn 41, Issue 9, 2002, Pages 734-737

  Okuda, Mitsutaka ^a   Nomura, Jun ^a   Tateno, Hiroo ^a   Kameoka, Junichi ^b   Sasaki, Takeshi ^b  

^a Miyagi Cancer Center   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; Jejunostomy; Natural killer cell like; Perforation of jejunem

Indexed keywords

CARBOPLATIN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISOLONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW DISEASE; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; DEATH; DRUG MEGADOSE; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INTESTINE LYMPHOMA; MALE; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PROGNOSIS; SMALL INTESTINE PERFORATION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; TUMOR DIFFERENTIATION;

EID: 0036745480     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.734     Document Type: Article

References (14)

1. Domizio P, Owen RA, Shpherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. Am J Surg Pathol 17: 429-442, 1993.
2. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 25: 1020-1029, 1994.
3. Chott A, Haedicke W, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+ CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153: 1483-1490, 1998.
4. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol 18: 795-803, 2000.
5. Blystad AK, Enblad G, Kvaloy S, et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 27: 711-716, 2001.
6. Chim CS, Au WY, Shek TW, et al. Primary CD56 positive lymphomas of the gastrointestinal tract. Cancer 91: 525-533, 2001.
7. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. New Engl J Med 329: 987-994, 1993.
8. Velasquez WS, McLaughlin P, Tucker S, et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow up study. J Clin Oncol 12: 1169-1176, 1994.
9. Koizumi K, Sawada K, Nishio M, et al. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantaion in a patient with the aggressive form of cytophagic histiocytic panniculitis. Bone Marrow Transplant 20: 171-173, 1997.
10. Katoh A, Ohshima K, Kanda M, et al. Gastrointestinal T cell lymphoma: Predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leukemia and Lymphoma 39: 97-111, 2000.
11. Spencer J, Cerf-Bensussan N, Jarry A, et al. Enteropathy associated T-cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132: 1-5, 1988.
12. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 141: 1361-1371, 1992.
13. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 87: 1474-1483, 1996.
14. Quintanilla-Martinez L, Lome-Maldonado C, Otto G, et al. Primary intestinal non-Hodgkin's lymphoma and Epstein-Barr virus: High frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leukemia and Lymphoma 30: 111-121, 1998.